Scientists used a “two cell type” whole genome CRISPR-Cas9 screening system to discover key regulators of tumor sensitivity and resistance to natural killer cell-mediated cytotoxicity in human glioblastoma stem cells.
[Nature Communications]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
174036
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
